Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Su... ((TM) (ACT) a validatedassessment questio...)

Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows

Date:5/20/2008

(TM) (ACT), a validated assessment questionnaire recommended by national treatment guidelines for determining a patient's level of asthma control. Of the more than 10,000 adults with self-reported asthma taking the ACT, 41 percent had a score of 19 or less, which indicates not well controlled asthma.

The survey also examined scores from the Childhood Asthma Control Test and ACT to determine the level of asthma control in more than 3,000 children respondents* between the ages of 4 and 17 and found that asthma control in children is also deficient. According to the findings, 31 percent of children with asthma between the ages of 4 and 11 and 25 percent of those between 12 and 17 did not have well-controlled asthma.

About the Asthma USA Survey

The Asthma USA study was conducted by GlaxoSmithKline in cooperation with National Family Opinion Survey Group and designed to evaluate uncontrolled asthma and assess demographic variables associated with asthma risk in the general population of the United States.

This was a cross sectional mailed survey administered to a representative national sample of 134,401 households recruited from a consumer panel of households managed by NFO/TNS in May, June and July 2007, a time when asthma-related medical complications traditionally see a seasonal decline. Surveys were returned for 60.6 percent of households, including information on 10,139 adults with a self-reported physician diagnosis of asthma completing the Asthma Control Test. Data for 38,323 children aged 4 to 17 was returned with a total of 1,991 children 4 to 11 years with asthma and 1,265 adolescents 12-17 years with asthma included in the survey.

The data presented at the ATS meeting represents the first phase of the study which is the baseline data. A subset of the initial population will be followed on a quarterly basis to generate longitudinal data on asthma control, missed work and school, medication use and seasonal variation in asthma
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
2. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
3. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
4. One Year On, ALLERCA Hypoallergenic Cats Bring Sneeze Free Companionship to Allergy and Asthma Sufferers
5. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
6. Drug Reduces Airway Mucus in Preclinical Asthma Model
7. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
10. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
11. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent

Post Your Comments:

Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Su...((TM) (ACT) a validatedassessment questio...)